HER2/neu Status on Pre and Post Neoadjuvant Chemotherapy

被引：0
|
作者：
Nofech-Mozes, S. [1 ]
Hanna, W. [1 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
262
引用
收藏
页码：60A / 61A
页数：2
相关论文
共 50 条
  • [31] Predictive Markers (ER, PR, HER2, HER2FISH) Pre- and Post-Neoadjuvant Chemotherapy in Primary Breast Carcinoma
    Darrow, M. D.
    Cohen, C.
    Nassar, A.
    LABORATORY INVESTIGATION, 2009, 89 : 36A - 36A
  • [32] Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer
    Fujita, Tetsuji
    LANCET, 2012, 379 (9833): : 2237 - 2237
  • [33] The effect of neoadjuvant chemotherapy on histologic grade and hormone receptor status in HER2/Neu-negative Luminal-B tumours of the breast
    Eren, O. C.
    Horoz, S. E.
    Ari, N.
    Menetlioglu, G.
    Kaya, H.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S65 - S66
  • [34] Her2/neu status in bone metastases of breast cancers
    Lörincz, T
    Tóth, J
    Szendröi, M
    Tímár, J
    PROCEEDINGS OF THE 2ND CONGRESS OF THE WORLD SOCIETY FOR BREAST HEALTH, 2003, : 35 - 38
  • [35] Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
    Heidy Cedeño
    Rafael Araúz
    Fernando Cebamanos
    Idalmis de Torraza
    Ana Porcell
    BMC Cancer, 7 (Suppl 1)
  • [36] Alterations in HER2 status and outcome following neoadjuvant chemotherapy in HER2-positive breast cancer (BC)
    Ng, Dianna
    Krings, Gregor
    Yau, Christina
    White, Kristie
    Hou, Jie
    Chua, Anthony
    Grenert, James P.
    Chen, Yunn-Yi
    CANCER RESEARCH, 2015, 75
  • [37] DCIS and HER2/neu
    Tulusan, AH
    ONKOLOGIE, 2002, 25 : 11 - 12
  • [38] Changes in ER, PR and HER2 receptors status after neoadjuvant chemotherapy in breast cancer
    Yang, Yu-Feng
    Liao, Ying-Yang
    Li, Le-Qun
    Xie, Shu-Rui
    Xie, Yan-Fang
    Peng, Ning-Fu
    PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (12) : 797 - 802
  • [39] The discordance of the ER, PR, and HER2 status after neoadjuvant chemotherapy in breast cancer.
    Ustaalioglu, Basak Oven
    Bilici, Ahmet
    Aker, Fugen Vardar
    Erkol, Burcak
    Aliustaoglu, Mehmet
    Gurleyik, Gunay
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Changes in ER, PgR and HER2 after neoadjuvant chemotherapy
    Kudaybergenova, A.
    Turkevich, E.
    Artemyeva, A.
    VIRCHOWS ARCHIV, 2016, 469 : S63 - S63
12345